Related Experiment Video
Updated: Jan 8, 2026

07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
Technology and Dementia Preconference
Joy Lai1, David Black2, Kelly Beaton2
1University of Toronto, Toronto, ON, Canada.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
Summary
Generative AI can improve dementia care by verifying tasks and supporting caregivers. This system enhances reminders and alerts, potentially reducing caregiver stress and improving support for people living with dementia.
Area of Science:
- Artificial Intelligence in Healthcare
- Gerontology and Dementia Care
- Human-Computer Interaction
Background:
- Caregivers of people living with dementia (PLwD) experience significant stress, with digital reminder systems offering limited task verification.
- Generative AI (e.g., GPT) presents a novel approach to enhance task verification and support caregiver decision-making in dementia care.
- This study explores the feasibility of an AI-powered system for task verification within a digital reminder framework for PLwD.
Purpose of the Study:
- To assess GPT's ability to generate high-quality, tailored follow-up questions for PLwD using few-shot prompting.
- To evaluate the accuracy of an AI system in identifying concerning responses from PLwD.
- To determine optimal strategies for balancing AI automation with essential caregiver control.
Main Methods:
- Simulated interactions using an anonymized dataset of 64 reminders involving caregivers, PLwD, and an AI system.
- Evaluation of GPT-generated follow-up questions for quality, with and without contextual information.
- Development of a flagging mechanism to categorize responses by concern level (High, Medium, Low), prioritizing safety and hygiene.
Main Results:
- Contextual information and caregiver feedback significantly improved the clarity, specificity, and relevance of AI-generated questions.
- The AI flagging mechanism demonstrated high accuracy for safety-critical tasks (e.g., medication, fall prevention) but showed subjectivity in non-urgent areas.
- Simulated caregiver feedback and input from members of the Engagement of People with Lived Experience of Dementia (EPLED) were crucial for system adaptation and evaluating stress reduction.
Conclusions:
- Integration of generative AI into dementia care is feasible, enhancing task verification and decision support.
- Contextual data, caregiver input, and lived experience perspectives are vital for optimizing AI system performance.
- AI-assisted verification holds potential for reducing caregiver stress and improving support for PLwD, warranting further real-world validation.
Related Concept Videos
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

